Clinical Trial Update: Repeated Infusions of Mesenchymal Stromal Cells in Children With Osteogenesis Imperfecta [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating repeated infusions of mesenchymal stromal cells in children with osteogenesis imperfecta has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteogenesis Imperfecta Type Ii
• Osteogenesis Imperfecta Type Iii

Drugs mentioned

• Mesenchymal stromal cells

Snippet

Sponsor: Nationwide Children's Hospital | Conditions: Osteogenesis Imperfecta Type II, Osteogenesis Imperfecta Type III | Phase 1 | Status: COMPLETED